SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-12-015266
Filing Date
2012-03-15
Accepted
2012-03-15 16:01:01
Documents
2
Period of Report
2012-04-16
Effectiveness Date
2012-03-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT v306203_def14a.htm DEF 14A 544021
2 GRAPHIC logo.jpg GRAPHIC 11620
  Complete submission text file 0001144204-12-015266.txt   561438
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 12694006
SIC: 2834 Pharmaceutical Preparations